GlassScriptPhysician profile
Kenneth J Fuquay
NPI 1225095599
$20,277.59
in general payments reported to CMS, 2019-2025
51 companies · $546 in 2025
The $546 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,721 · 2020: $6,197 · 2021: $1,941 · 2022: $1,940 · 2023: $3,564 · 2024: $2,368 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,518 · Gift: $684 · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,517.63 |
| Gift | $683.85 |
| Education | $277.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,591.43 | 2019-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $2,674.44 | 2019-2025 | Fasenra, Tezspire, Tagrisso |
| Glaxosmithkline, LLC. | $1,402.59 | 2019-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,084.04 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Pulmonx Corporation | $1,033.69 | 2019-2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Actelion Pharmaceuticals US, INC. | $619.68 | 2021-2024 | Uptravi, Opsumit |
| Genzyme Corporation | $584.19 | 2021-2025 | |
| Amgen INC. | $527.53 | 2021-2025 | Tezspire |
| Mylan Specialty L.P. | $435.52 | 2019-2024 | Yupelri |
| Ethicon INC. | $417.40 | 2019 | |
| Philips North America LLC | $298.23 | 2019-2024 | (Ak6) Vest Therapy |
| Regeneron Healthcare Solutions, INC. | $287.36 | 2021-2024 | Dupixent |
| Inogen, INC. | $281.31 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pfizer INC. | $267.51 | 2020-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $246.99 | 2019-2024 | Hyqvia |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $214.82 | 2021-2025 | Tyvaso, Tyvaso |
| Fisher & Paykel Healthcare INC | $203.66 | 2022-2024 | Fisher & Paykel Healthcare |
| Genentech USA, INC. | $193.19 | 2019 | |
| Fujifilm Healthcare Americas Corporation | $180.01 | 2022-2024 | Fujifilm |
| Sanofi-Aventis U.S. LLC | $176.94 | 2022-2023 | |
| Olympus America INC. | $130.93 | 2024 | Spiration Valve System |
| Grifols USA, LLC | $122.06 | 2019-2024 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $112.49 | 2020 | |
| Optinose US, INC. | $99.96 | 2019 | |
| Baxter Healthcare | $91.32 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $89.32 | 2020-2024 | Arikayce |
| Inspire Medical Systems, INC. | $88.50 | 2023 | Inspire |
| Boston Scientific Corporation | $63.57 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $60.31 | 2019 | |
| Gilead Sciences, INC. | $52.67 | 2021 | |
| Advanced Respiratory, INC | $52.67 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.59 | 2023-2024 | |
| Electromed, INC. | $45.24 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $43.41 | 2019-2021 | |
| Lilly USA, LLC | $40.55 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $36.45 | 2020 | |
| Octapharma USA, INC. | $34.51 | 2021 | |
| Verona Pharma, INC. | $32.37 | 2025 | Ohtuvayre |
| Ani Pharmaceuticals, INC. | $31.99 | 2024 | Purified Cortrophin Gel |
| Mayne Pharma Commercial LLC | $31.82 | 2021 | |
| Vifor Pharma, INC. | $29.22 | 2024 | Zemaira |
| Ambu INC. | $26.34 | 2025 | |
| Merck Sharp & Dohme LLC | $26.12 | 2024 | Winrevair |
| Phadia US INC. | $24.62 | 2024 | Immunocap |
| Nabriva Therapeutics, Plc | $23.61 | 2022 | |
| Abbvie INC. | $23.40 | 2024 | |
| Veran Medical Technologies, INC. | $22.88 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $20.95 | 2021 | |
| Body Vision Medical INC. | $19.79 | 2023 | Lungvision |
| Zoll Respicardia, INC. | $14.56 | 2025 | Remede System |
| Horizon Therapeutics Plc | $12.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Fuquay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.